Ming Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ming Li has a total of 530 co-authors. Here are the top co-authors by number of shared publications:
- Xiao Xiao
State Key Laboratory of Genetic Evolution & Animal Models, Yunnan Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
29 shared publications Xiao Xiao
Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
25 shared publicationsHong Chang
State Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan, China
24 shared publicationsLu Wang
State Key Laboratory of Genetic Evolution & Animal Models, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
24 shared publications- Xiong-Jian Luo
Department of Psychosomatics and Psychiatry, School of Medicine, Advanced Institute for Life and Health, Jiangsu Provincial Key Laboratory of Brain Science and Medicine, Zhongda Hospital, Southeast University, Nanjing, China
18 shared publications Jiewei Liu
Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
15 shared publications
Latest Publications
- 27 August 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-9
Higher frequencies of CNV deletions in bipolar disorder among Chinese Population
- 27 August 2026
- Published by Springer Nature in Molecular Psychiatry
- p. 1-9
Higher frequencies of CNV deletions in bipolar disorder among Chinese Population
- Open Access
- 16 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (3) , eadw7667
A causal coding variant regulating alternative splicing of DOC2A at 16p.11.2 GWAS locus influences susceptibility to schizophrenia
Although genome-wide association studies (GWASs) have identified many schizophrenia-associated variants, their biological mechanisms remain unclear. Using transcriptomic data from human brain tissues, we performed splicing quantitative trait locus (sQTL) analyses of schizophrenia-associated single-nucleotide polymorphisms and identified more than 17,000 sQTLs linked to previously unidentified splicing junctions. Functional prioritization and experimental validation highlighted the synonymous variant rs3935873 within the 16p11.2 GWAS locus strongly associated with an unannotated isoform DOC2A ∆ Val217-Pro218 . rs3935873 was significantly associated with hippocampal volume, and hippocampal overexpression of DOC2A ∆Val217-Pro218 in mice recapitulated schizophrenia-relevant behavioral deficits, phenotypes absent in DOC2A Full-Length -overexpressing mice. Overexpression of both isoforms altered excitatory synaptic transmission, structural modeling revealed divergent tertiary configurations between DOC2A ∆Val217-Pro218 and DOC2A Full-Length , and interactome profiling highlighted that DOC2A ∆Val217-Pro218 unique interactors are enriched in the myosin II complex and ankyrin binding, suggesting the acquisition of previously unknown structural and regulatory functions by DOC2A ∆Val217-Pro218 . Our study implicates dysregulated splicing in DOC2A as a functional mechanism for schizophrenia genetic risk and demonstrates how unannotated isoforms can reveal disease-relevant pathways.
- 16 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (3) , eadw7667
Open AccessA causal coding variant regulating alternative splicing of DOC2A at 16p.11.2 GWAS locus influences susceptibility to schizophrenia
Although genome-wide association studies (GWASs) have identified many schizophrenia-associated variants, their biological mechanisms remain unclear. Using transcriptomic data from human brain tissues, we performed splicing quantitative trait locus (sQTL) analyses of schizophrenia-associated single-nucleotide polymorphisms and identified more than 17,000 sQTLs linked to previously unidentified splicing junctions. Functional prioritization and experimental validation highlighted the synonymous variant rs3935873 within the 16p11.2 GWAS locus strongly associated with an unannotated isoform DOC2A ∆ Val217-Pro218 . rs3935873 was significantly associated with hippocampal volume, and hippocampal overexpression of DOC2A ∆Val217-Pro218 in mice recapitulated schizophrenia-relevant behavioral deficits, phenotypes absent in DOC2A Full-Length -overexpressing mice. Overexpression of both isoforms altered excitatory synaptic transmission, structural modeling revealed divergent tertiary configurations between DOC2A ∆Val217-Pro218 and DOC2A Full-Length , and interactome profiling highlighted that DOC2A ∆Val217-Pro218 unique interactors are enriched in the myosin II complex and ankyrin binding, suggesting the acquisition of previously unknown structural and regulatory functions by DOC2A ∆Val217-Pro218 . Our study implicates dysregulated splicing in DOC2A as a functional mechanism for schizophrenia genetic risk and demonstrates how unannotated isoforms can reveal disease-relevant pathways.
- 25 November 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (2) , 293-305
Trans-ancestry genome-wide analyses of bipolar disorder in East Asian and European populations improve genetic discovery
Genome-wide association studies (GWASs) of bipolar disorder (BD) have predominantly included individuals of European (EUR) ancestry, underrepresenting non-EUR populations and limiting insight into disease mechanisms. Here we performed a GWAS of BD in Han Chinese individuals (5,164 cases and 13,460 controls) and conducted comparative and integrative analyses with independent East Asian (EAS, 4,479 cases and 75,725 controls) and EUR (59,287 cases and 781,022 controls) cohorts from the PGC4 GWAS. Our GWAS in EAS ancestry identified two genome-wide significant risk loci, including variants at the major histocompatibility complex (MHC) class II region. Incorporating EAS data into trans-ancestry GWAS revealed 93 significant loci (23 novel). Heritability enrichment analyses implicated a variety of neuronal cell types. Multidimensional post-GWAS prioritization identified 39 high-confidence risk genes, of which 15 were differentially expressed in the brains of patients with BD, 12 modulated BD-relevant behaviors in mice and 18 are pharmacologically tractable. This work advances understanding of the biological underpinnings of BD and provides direction for future research in underrepresented populations.
- 25 November 2025
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (2) , 293-305
Trans-ancestry genome-wide analyses of bipolar disorder in East Asian and European populations improve genetic discovery
Genome-wide association studies (GWASs) of bipolar disorder (BD) have predominantly included individuals of European (EUR) ancestry, underrepresenting non-EUR populations and limiting insight into disease mechanisms. Here we performed a GWAS of BD in Han Chinese individuals (5,164 cases and 13,460 controls) and conducted comparative and integrative analyses with independent East Asian (EAS, 4,479 cases and 75,725 controls) and EUR (59,287 cases and 781,022 controls) cohorts from the PGC4 GWAS. Our GWAS in EAS ancestry identified two genome-wide significant risk loci, including variants at the major histocompatibility complex (MHC) class II region. Incorporating EAS data into trans-ancestry GWAS revealed 93 significant loci (23 novel). Heritability enrichment analyses implicated a variety of neuronal cell types. Multidimensional post-GWAS prioritization identified 39 high-confidence risk genes, of which 15 were differentially expressed in the brains of patients with BD, 12 modulated BD-relevant behaviors in mice and 18 are pharmacologically tractable. This work advances understanding of the biological underpinnings of BD and provides direction for future research in underrepresented populations.
- Open Access
- 18 November 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 479
Identification of 1q25.2 as a novel shared locus between schizophrenia and major depressive disorder in east Asians by integrative analyses
Schizophrenia (SZ) and major depressive disorder (MDD) share psychopathological features, and their overlapped genetic architectures have been well-studied in Europeans. However, the extent of their polygenic overlap in East Asians remains unclear. Genome-wide association study (GWAS) datasets present a valuable resource for exploring this question. We applied linkage disequilibrium score (LDSC) regression and MiXeR analyses to assess polygenic overlap. Cross-trait meta-analysis was used to identify shared genomic loci between disorders. Expression quantitative trait loci (eQTL) and diagnostic analyses of mRNA expression were utilized to localize risk gene(s). Using GWAS datasets of SZ (29,519 cases and 44,392 controls) and MDD (7753 cases and 14,046 controls), we conducted LDSC regression and MiXeR analyses, revealing substantial genetic overlap between the two disorders. Genome-wide meta-analysis highlighted a novel risk locus at 1q25.2. The risk SNPs at this locus showed significant eQTL associations with FAM20B mRNA expression across the brain and blood, consistent with higher gene expression observed in cases. We highlighted a novel genome-wide risk locus in East Asians linked to SZ and MDD, reinforcing evidence for their shared genetic overlap. Our study emphasizes the significance of mining public datasets to explore psychiatric risk genes.
- 18 November 2025
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 479
Open AccessIdentification of 1q25.2 as a novel shared locus between schizophrenia and major depressive disorder in east Asians by integrative analyses
Schizophrenia (SZ) and major depressive disorder (MDD) share psychopathological features, and their overlapped genetic architectures have been well-studied in Europeans. However, the extent of their polygenic overlap in East Asians remains unclear. Genome-wide association study (GWAS) datasets present a valuable resource for exploring this question. We applied linkage disequilibrium score (LDSC) regression and MiXeR analyses to assess polygenic overlap. Cross-trait meta-analysis was used to identify shared genomic loci between disorders. Expression quantitative trait loci (eQTL) and diagnostic analyses of mRNA expression were utilized to localize risk gene(s). Using GWAS datasets of SZ (29,519 cases and 44,392 controls) and MDD (7753 cases and 14,046 controls), we conducted LDSC regression and MiXeR analyses, revealing substantial genetic overlap between the two disorders. Genome-wide meta-analysis highlighted a novel risk locus at 1q25.2. The risk SNPs at this locus showed significant eQTL associations with FAM20B mRNA expression across the brain and blood, consistent with higher gene expression observed in cases. We highlighted a novel genome-wide risk locus in East Asians linked to SZ and MDD, reinforcing evidence for their shared genetic overlap. Our study emphasizes the significance of mining public datasets to explore psychiatric risk genes.
- Open Access
- 8 September 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (37)
Microglia contribute to bipolar depression through Serinc2-dependent phospholipid synthesis
Although clinical research has revealed microglia-related inflammatory and immune responses in bipolar disorder (BD) patient brains, it remains unclear how microglia contribute to the pathogenesis of BD. Here, we demonstrated that Serinc2 is associated with susceptibility to BD and showed a reduced expression in BDII patient plasma, which correlated with the disease severity. Using induced pluripotent stem cell (iPSC) models of sporadic and familial BDII patients, we found that Serinc2 expression showed deficits in iPSC-derived microglia-like cells, resulting in decreased synaptic pruning. Further, combining the microglia-specific Serinc2-deficient mouse and iPSC-microglia models, we found that microglial Serinc2 deficits functioned through attenuating the synthesis of serine-related phospholipids in the plasma membrane, thus resulting in depression-like behavioral abnormalities in the animals. Finally, we showed that the Serinc2-dependent lipid deficits diminished microglial membrane CR3 formation to interrupted synaptic pruning signals from neurons. Therefore, our results indicated that Serinc2 deficits in microglia might contribute to the pathogenesis of BD.
- 8 September 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (37)
Open AccessMicroglia contribute to bipolar depression through Serinc2-dependent phospholipid synthesis
Although clinical research has revealed microglia-related inflammatory and immune responses in bipolar disorder (BD) patient brains, it remains unclear how microglia contribute to the pathogenesis of BD. Here, we demonstrated that Serinc2 is associated with susceptibility to BD and showed a reduced expression in BDII patient plasma, which correlated with the disease severity. Using induced pluripotent stem cell (iPSC) models of sporadic and familial BDII patients, we found that Serinc2 expression showed deficits in iPSC-derived microglia-like cells, resulting in decreased synaptic pruning. Further, combining the microglia-specific Serinc2-deficient mouse and iPSC-microglia models, we found that microglial Serinc2 deficits functioned through attenuating the synthesis of serine-related phospholipids in the plasma membrane, thus resulting in depression-like behavioral abnormalities in the animals. Finally, we showed that the Serinc2-dependent lipid deficits diminished microglial membrane CR3 formation to interrupted synaptic pruning signals from neurons. Therefore, our results indicated that Serinc2 deficits in microglia might contribute to the pathogenesis of BD.
- Open Access
- 23 May 2025
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 52 (1)
Schizophrenia-Related Synaptic Dysfunction and Abnormal Sensorimotor Gating in Akap11 -Deficient Mice
Background and Hypothesis: Large-scale whole exome sequencing (WES) analyses have implicated rare protein-truncating variants (PTVs) in the AKAP11 gene contributing to schizophrenia risk. Previous studies reported alterations of EEG characteristics and synaptic proteome in Akap11 mutant mice. We hypothesize that synaptic dysfunction contributes to AKAP11 deficiency in the pathogenesis of schizophrenia. Study Design: We generated an Akap11 knockout mouse and employed a series of behavioral evaluations, neuronal sparse labeling assays, electron microscopy, and immunoprecipitation mass spectrometry (IP-MS) to elucidate the impacts of Akap11 on schizophrenia-relevant phenotypes. Study Results: Our behavioral paradigm evaluations revealed that Akap11 deficient mice exhibited impaired prepulse inhibition and anxiety-like behaviors compared with their wild-type littermates. Neuronal sparse labeling assays indicated a significant reduction in the density of total and thin spines in Akap11 deficient mice, and ultrastructural analysis via electron microscopy disclosed marked alterations in synaptogenesis after suppressing Akap11, including the reduced density of typical synapses, synaptic vesicle density, and postsynaptic density (PSD) length. IP-MS identified 222 high-confidence interaction proteins of Akap11, encompassing synapses-related proteins (eg, Exoc4, Ncam1, Picalm, Vapb) and actin-related proteins (Actb, Diaph1), and enrichment analyses further showed that Akap11 may contribute to RNA splicing, extracellular matrix organization, axon guidance, post-NMDA receptor activation events, GPER1 signaling and PKA activation pathways. Conclusions: Together, these findings delineated the synaptic and behavioral phenotypes in Akap11 deficient mice, shedding light on the potential mechanisms underlying the role of rare PTVs in schizophrenia and substantiating the significance of AKAP11 as a risk gene for this illness.
- 23 May 2025
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 52 (1)
Open AccessSchizophrenia-Related Synaptic Dysfunction and Abnormal Sensorimotor Gating in Akap11 -Deficient Mice
Background and Hypothesis: Large-scale whole exome sequencing (WES) analyses have implicated rare protein-truncating variants (PTVs) in the AKAP11 gene contributing to schizophrenia risk. Previous studies reported alterations of EEG characteristics and synaptic proteome in Akap11 mutant mice. We hypothesize that synaptic dysfunction contributes to AKAP11 deficiency in the pathogenesis of schizophrenia. Study Design: We generated an Akap11 knockout mouse and employed a series of behavioral evaluations, neuronal sparse labeling assays, electron microscopy, and immunoprecipitation mass spectrometry (IP-MS) to elucidate the impacts of Akap11 on schizophrenia-relevant phenotypes. Study Results: Our behavioral paradigm evaluations revealed that Akap11 deficient mice exhibited impaired prepulse inhibition and anxiety-like behaviors compared with their wild-type littermates. Neuronal sparse labeling assays indicated a significant reduction in the density of total and thin spines in Akap11 deficient mice, and ultrastructural analysis via electron microscopy disclosed marked alterations in synaptogenesis after suppressing Akap11, including the reduced density of typical synapses, synaptic vesicle density, and postsynaptic density (PSD) length. IP-MS identified 222 high-confidence interaction proteins of Akap11, encompassing synapses-related proteins (eg, Exoc4, Ncam1, Picalm, Vapb) and actin-related proteins (Actb, Diaph1), and enrichment analyses further showed that Akap11 may contribute to RNA splicing, extracellular matrix organization, axon guidance, post-NMDA receptor activation events, GPER1 signaling and PKA activation pathways. Conclusions: Together, these findings delineated the synaptic and behavioral phenotypes in Akap11 deficient mice, shedding light on the potential mechanisms underlying the role of rare PTVs in schizophrenia and substantiating the significance of AKAP11 as a risk gene for this illness.
- Open Access
- 23 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (21) , eadr2291
Hippocampal Zkscan4 confers resilience to chronic stress–induced depression-like behaviors
Major depression is a prevalent and devastating psychiatric disorder. However, our understanding of the underlying molecular mechanisms is limited. Here, we found reduced expression of zinc finger protein with Krüppel-associated box and SCAN domains 4 (Zkscan4) in the hippocampi of patients with major depressive disorder and stress-susceptible mice. Zkscan4 disruption ( Zkscan4 −/− ) was sufficient to induce depression-like behaviors following subthreshold social stress. Zkscan4 regulated excitatory synaptic transmission mainly through direct interaction with the Htr2a promoter and the recruitment of glucocorticoid receptors for the transcriptional repression of 5-hydroxytryptamine receptor 2a (Htr2a). Reduced excitatory synaptic transmission in the hippocampus and stress susceptibility in Zkscan4 −/− mice were restored by pharmacological inhibition, genetic knockdown of Htr2a, or overexpression of the amino-terminal SCAN domain of Zkscan4 (Zkscan4 1–133 ) in cornus ammonis region 3. Our findings demonstrate an essential role of Zkscan4 in promoting stress resilience, suggesting a potential antidepressant effect of Zkscan4 1–133 .
- 23 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (21) , eadr2291
Open AccessHippocampal Zkscan4 confers resilience to chronic stress–induced depression-like behaviors
Major depression is a prevalent and devastating psychiatric disorder. However, our understanding of the underlying molecular mechanisms is limited. Here, we found reduced expression of zinc finger protein with Krüppel-associated box and SCAN domains 4 (Zkscan4) in the hippocampi of patients with major depressive disorder and stress-susceptible mice. Zkscan4 disruption ( Zkscan4 −/− ) was sufficient to induce depression-like behaviors following subthreshold social stress. Zkscan4 regulated excitatory synaptic transmission mainly through direct interaction with the Htr2a promoter and the recruitment of glucocorticoid receptors for the transcriptional repression of 5-hydroxytryptamine receptor 2a (Htr2a). Reduced excitatory synaptic transmission in the hippocampus and stress susceptibility in Zkscan4 −/− mice were restored by pharmacological inhibition, genetic knockdown of Htr2a, or overexpression of the amino-terminal SCAN domain of Zkscan4 (Zkscan4 1–133 ) in cornus ammonis region 3. Our findings demonstrate an essential role of Zkscan4 in promoting stress resilience, suggesting a potential antidepressant effect of Zkscan4 1–133 .
- 24 February 2025
- Published by Springer Nature in Nature Human Behaviour
- Vol. 9 (4) , 806-823
Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression
Deciphering the genetic architecture of depression is pivotal for characterizing the associated pathophysiological processes and development of new therapeutics. Here we conducted a cross-ancestry genome-wide meta-analysis on depression (416,437 cases and 1,308,758 controls) and identified 287 risk loci, of which 49 are new. Variant-level fine mapping prioritized potential causal variants and functional genomic analysis identified variants that regulate the binding of transcription factors. We validated that 80% of the identified functional variants are regulatory variants, and expression quantitative trait loci analysis uncovered the potential target genes regulated by the prioritized risk variants. Gene-level analysis, including transcriptome and proteome-wide association studies, colocalization and Mendelian randomization-based analyses, prioritized potential causal genes and drug targets. Gene prioritization analyses highlighted likely causal genes, including TMEM106B, CTNND1, AREL1 and so on. Pathway analysis indicated significant enrichment of depression risk genes in synapse-related pathways. Finally, knockdown of Tmem106b in mice resulted in depression-like behaviours, supporting the involvement of Tmem106b in depression. Our study identified new risk loci, likely causal variants and genes for depression, providing important insights into the genetic architecture of depression and potential therapeutic targets.
- 24 February 2025
- Published by Springer Nature in Nature Human Behaviour
- Vol. 9 (4) , 806-823
Cross-ancestry genome-wide association study and systems-level integrative analyses implicate new risk genes and therapeutic targets for depression
Deciphering the genetic architecture of depression is pivotal for characterizing the associated pathophysiological processes and development of new therapeutics. Here we conducted a cross-ancestry genome-wide meta-analysis on depression (416,437 cases and 1,308,758 controls) and identified 287 risk loci, of which 49 are new. Variant-level fine mapping prioritized potential causal variants and functional genomic analysis identified variants that regulate the binding of transcription factors. We validated that 80% of the identified functional variants are regulatory variants, and expression quantitative trait loci analysis uncovered the potential target genes regulated by the prioritized risk variants. Gene-level analysis, including transcriptome and proteome-wide association studies, colocalization and Mendelian randomization-based analyses, prioritized potential causal genes and drug targets. Gene prioritization analyses highlighted likely causal genes, including TMEM106B, CTNND1, AREL1 and so on. Pathway analysis indicated significant enrichment of depression risk genes in synapse-related pathways. Finally, knockdown of Tmem106b in mice resulted in depression-like behaviours, supporting the involvement of Tmem106b in depression. Our study identified new risk loci, likely causal variants and genes for depression, providing important insights into the genetic architecture of depression and potential therapeutic targets.
- 18 February 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (8) , 3466-3477
Human mood disorder risk gene Synaptotagmin-14 contributes to mania-like behaviors in mice
Bipolar disorder (BD) and major depressive disorder (MDD) are the most prevalent mood disorders and cause considerable burden worldwide. Compelling evidence suggests a pronounced overlap between these two disorders in clinical symptoms, treatment strategies, and genetic etiology. Here we leverage a BD GWAS (1822 cases and 4650 controls) and a MDD GWAS (5303 cases and 5337 controls), followed by independent replications, to investigate their shared genetic basis among Han Chinese. We have herein identified a lead SNP rs126277 at the 1q32.2 locus, which also exhibited nominal associations with mood disorders and several relevant sub-clinical phenotypes (e.g., mania) in European populations. Bulk tissue and single-cell eQTL analyses suggest that the risk G-allele of rs126277 predicted lower SYT14 mRNA expression in human brains. We generated mice lacking Syt14 (Syt14–/–) and mice with insufficient expression of Syt14 in the hippocampus (Syt14-KD), and found that depletion of Syt14 resulted in mania-like behaviors including hyperactivity and anti-depressive behaviors, resembling aspects of mood disorders. We also confirmed that deficiency of this gene in the hippocampus was sufficient to induce hyperactivity in mice. RNA-sequencing analyses of the hippocampus of Syt14–/– mice revealed significant upregulation of Per1 as well as downregulation of Slc7a11 and Ptprb. Ultrastructural analyses showed significant alteration of the number of vesicles within 50 nm to the active zone and the width of synaptic cleft in the ventral hippocampus of Syt14–/– mice compared with the control mice. Overall, we have identified a novel mood disorder risk gene SYT14, and confirmed its impact on mania-like behaviors. While the current study identifies an essential mood disorder risk gene, further investigations elucidating the detailed mechanisms by which SYT14 contributes to the pathogenesis of the illnesses are needed.
- 18 February 2025
- Published by Springer Nature in Molecular Psychiatry
- Vol. 30 (8) , 3466-3477
Human mood disorder risk gene Synaptotagmin-14 contributes to mania-like behaviors in mice
Bipolar disorder (BD) and major depressive disorder (MDD) are the most prevalent mood disorders and cause considerable burden worldwide. Compelling evidence suggests a pronounced overlap between these two disorders in clinical symptoms, treatment strategies, and genetic etiology. Here we leverage a BD GWAS (1822 cases and 4650 controls) and a MDD GWAS (5303 cases and 5337 controls), followed by independent replications, to investigate their shared genetic basis among Han Chinese. We have herein identified a lead SNP rs126277 at the 1q32.2 locus, which also exhibited nominal associations with mood disorders and several relevant sub-clinical phenotypes (e.g., mania) in European populations. Bulk tissue and single-cell eQTL analyses suggest that the risk G-allele of rs126277 predicted lower SYT14 mRNA expression in human brains. We generated mice lacking Syt14 (Syt14–/–) and mice with insufficient expression of Syt14 in the hippocampus (Syt14-KD), and found that depletion of Syt14 resulted in mania-like behaviors including hyperactivity and anti-depressive behaviors, resembling aspects of mood disorders. We also confirmed that deficiency of this gene in the hippocampus was sufficient to induce hyperactivity in mice. RNA-sequencing analyses of the hippocampus of Syt14–/– mice revealed significant upregulation of Per1 as well as downregulation of Slc7a11 and Ptprb. Ultrastructural analyses showed significant alteration of the number of vesicles within 50 nm to the active zone and the width of synaptic cleft in the ventral hippocampus of Syt14–/– mice compared with the control mice. Overall, we have identified a novel mood disorder risk gene SYT14, and confirmed its impact on mania-like behaviors. While the current study identifies an essential mood disorder risk gene, further investigations elucidating the detailed mechanisms by which SYT14 contributes to the pathogenesis of the illnesses are needed.
- Open Access
- 24 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
NEK4 modulates circadian fluctuations of emotional behaviors and synaptogenesis in male mice
GWASs have linked the 3p21.1 locus, which is associated with the expression levels of NEK4, to bipolar disorder. Here, we use integrative analyses of GWAS statistics and eQTL annotations to establish that elevated NEK4 expression in the hippocampus is associated with an increased risk of bipolar disorder. To further study this association, we generate transgenic male mice that conditionally overexpress NEK4 in the pyramidal neurons of the adult forebrain, or use AAV to overexpress NEK4 in the dorsal hippocampus. Compared to the control mice, male mice of both strains exhibit a shift from a diurnal anxiety state to a nocturnal normal or anxiolytic-like state. Overexpression of NEK4 also affects the circadian fluctuations in dendritic spine morphology and synaptic structure. Furthermore, we show that treatment with lithium ameliorates the effects of NEK4 overexpression in male mice. We then perform phosphoproteomic analyses to demonstrate that the diurnal and nocturnal phosphoproteomic profiles of male control and NEK4 overexpressing mice are different. These results suggest that male mice with different NEK4 expression levels may recapitulate some of the core features observed in patients with bipolar disorder, indicating that interruption of the homeostatic dynamics of synapses may underlie the emotional swings in bipolar disorder.
- 24 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessNEK4 modulates circadian fluctuations of emotional behaviors and synaptogenesis in male mice
GWASs have linked the 3p21.1 locus, which is associated with the expression levels of NEK4, to bipolar disorder. Here, we use integrative analyses of GWAS statistics and eQTL annotations to establish that elevated NEK4 expression in the hippocampus is associated with an increased risk of bipolar disorder. To further study this association, we generate transgenic male mice that conditionally overexpress NEK4 in the pyramidal neurons of the adult forebrain, or use AAV to overexpress NEK4 in the dorsal hippocampus. Compared to the control mice, male mice of both strains exhibit a shift from a diurnal anxiety state to a nocturnal normal or anxiolytic-like state. Overexpression of NEK4 also affects the circadian fluctuations in dendritic spine morphology and synaptic structure. Furthermore, we show that treatment with lithium ameliorates the effects of NEK4 overexpression in male mice. We then perform phosphoproteomic analyses to demonstrate that the diurnal and nocturnal phosphoproteomic profiles of male control and NEK4 overexpressing mice are different. These results suggest that male mice with different NEK4 expression levels may recapitulate some of the core features observed in patients with bipolar disorder, indicating that interruption of the homeostatic dynamics of synapses may underlie the emotional swings in bipolar disorder.